Emergent BioSolutions Inc. (BOATS:EBS) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Karen Smith Other companies: Context Therapeutics Inc. (Independent Director · Since at least Sep 4, 2024); Skye Bioscience, Inc. (Director · Since at least Jul 2, 2024); Sangamo Therapeutics, Inc. (Director · Since at least Jun 26, 2018); Aurinia Pharmaceuticals Inc (Director · Aug 18, 2023 – Nov 21, 2024 · Past); Quince Therapeutics, Inc. (Chief Medical Officer · May 19, 2022 – Feb 1, 2023 · Past); Tourmaline Bio Inc. (Director · May 16, 2022 – Jun 13, 2023 · Past); Antares Pharma Inc (Director · Mar 1, 2019 – May 24, 2022 · Past); Acceleron Pharma Inc (Director · Nov 15, 2017 – Nov 19, 2021 · Past); Sucampo Pharmaceuticals Inc (Director · Jul 15, 2017 – Feb 13, 2018 · Past); Jazz Pharmaceuticals plc (EVP, R&D and CMO · Apr 13, 2015 – Mar 5, 2018 · Past) | EVP, Chief Medical Officer · May 21, 2020 – May 7, 2021 · Past |
| Louis W Sullivan Other companies: United Therapeutics Corporation (Director · Since at least Jun 26, 2006); ANI Pharmaceuticals, Inc. (Director · Mar 16, 2006 – Mar 30, 2012 · Past); Henry Schein, Inc. (Director · Mar 2, 2006 – Mar 31, 2016 · Past); Inhibitex Inc (Director · Feb 1, 2006 – Feb 1, 2007 · Past); 3M Company (Director · Dec 31, 2005 – May 9, 2006 · Past); The Cigna Group (Director · Dec 31, 2005 – Jun 1, 2006 · Past); Bristol-Myers Squibb Company (Director · Dec 30, 2005 – Mar 31, 2006 · Past) | Director · Nov 14, 2006 – Apr 30, 2025 · Past |
| Joseph Papa Other companies: Milestone Pharmaceuticals Inc. (Independent Non-Executive Director · Since at least Sep 3, 2024); Candel Therapeutics, Inc. (Chairman · Since at least Aug 8, 2022); Bausch + Lomb Corporation (See Remarks, Director · May 5, 2022 – May 5, 2022 · Past); Prometheus Biosciences Inc (Director · Mar 11, 2021 – Jun 16, 2023 · Past); Bausch Health Companies Inc. (Director · May 2, 2016 – May 10, 2022 · Past); Perrigo Company plc (Director · Oct 9, 2006 – Feb 26, 2016 · Past) | President and Chief Executive Officer · Since at least Feb 21, 2024 |
| Keith A. Katkin Other companies: Eledon Pharmaceuticals, Inc. (Chairman of the Board of Directors · Since at least May 10, 2017); Syndax Pharmaceuticals, Inc. (Director · Since at least Mar 29, 2017); Urovant Sciences Ltd (PEO;CEO/Urovant Sciences, Inc., Director · Sep 26, 2018 – Feb 19, 2020 · Past); Rigel Pharmaceuticals, Inc. (Director · Jun 29, 2015 – May 19, 2021 · Past); Carbylan Therapeutics Inc (Director · Apr 8, 2015 – Aug 3, 2015 · Past); Avanir Pharmaceuticals Inc (President and CEO, Director · May 15, 2013 – Dec 15, 2014 · Past) | Independent Director · Since at least Apr 1, 2022 |
| Barry Labinger Other companies: Checkmate Pharmaceuticals Inc (President and CEO, Director · Aug 6, 2020 – Aug 4, 2021 · Past); Anadys Pharmaceuticals Inc (Director · Mar 11, 2011 – May 27, 2011 · Past); Human Genome Sciences Inc (Exec VP & CCO · Mar 14, 2006 – Jul 30, 2012 · Past) | EVP, Biosciences Div. · Aug 12, 2013 – Nov 13, 2015 · Past |
| Marvin L. White Other companies: Aptevo Therapeutics Inc. (Executive Chair · Since at least Jul 29, 2016); CoLucid Pharmaceuticals Inc (Director · Jul 9, 2015 – Mar 1, 2017 · Past); Washington Prime Group Inc (Director · May 8, 2014 – Aug 4, 2014 · Past) | Independent Director · Since at least Jun 1, 2010 |
| Neal Fowler Other companies: Liquidia Corporation (Chief Executive Officer, Director · Nov 19, 2020 – Nov 19, 2020 · Past); Aralez Pharmaceuticals Inc (Director · Feb 5, 2016 – May 11, 2017 · Past); POZEN Inc (Director · Jun 10, 2010 – Jul 28, 2015 · Past) | Independent Director · Since at least Oct 1, 2023 |
| Richard S. Lindahl Other companies: Compass Therapeutics, Inc. (Executive Vice President, Chief Financial Officer and Treasurer, Emergent BioSolutions · Since at least Apr 21, 2023); The Corporate Executive Board Company (Chief Financial Officer · Mar 27, 2013 – Apr 27, 2015 · Past); SPRINT Corp (Treasurer · Feb 7, 2006 – Aug 4, 2008 · Past) | Executive Vice President · Since at least Mar 26, 2018 |
| Atul Saran Other companies: MacroGenics, Inc. (SVP & General Counsel · Jun 5, 2014 – Apr 28, 2017 · Past); Xencor, Inc. (Director · Dec 2, 2013 – Dec 6, 2013 · Past) | EVP, Chief Strat & Dev Officer · Jul 20, 2017 – Feb 28, 2023 · Past |
| Daniel J. Abdun-Nabi Other companies: Aptevo Therapeutics Inc. (President · Since at least Aug 1, 2016); Regenxbio Inc. (Director · Aug 5, 2016 – Jun 4, 2021 · Past) | CEO, Director · Nov 14, 2006 – Mar 4, 2019 · Past |
| Don DeGolyer Other companies: Tyme Technologies Inc (Director · May 24, 2018 – Sep 16, 2022 · Past); Endo International PLC (Chief Operating Officer,Pharma · Feb 28, 2014 – Feb 26, 2015 · Past) | Director · Since at least Oct 1, 2023 |
| Fuad El-Hibri Other companies: Aptevo Therapeutics Inc. (Director · Aug 1, 2016 – Dec 3, 2021 · Past) | Director · Nov 14, 2006 – Dec 3, 2021 · Past |
| George A Joulwan Other companies: General Dynamics Corporation (Director · Jan 3, 2006 – Mar 12, 2012 · Past) | Director · Jul 17, 2013 – May 26, 2022 · Past |
| Jennifer Fox Other companies: Myriad Genetics, Inc. (Chief Legal Officer · Since at least Sep 3, 2024) | EVP, Ext Aff, GC, Corp Sec · Mar 1, 2022 – Jul 11, 2024 · Past |
| Joe M Allbaugh Other companies: Ecosphere Technologies Inc (Director · Jul 1, 2009 – Jul 1, 2011 · Past) | Director · Nov 14, 2006 – May 21, 2008 · Past |
| John D Fowler Jr Other companies: Beverly Enterprises Inc (Director · Mar 14, 2006 – Mar 14, 2006 · Past) | Director · Since at least Mar 1, 2026 |
| John E. Niederhuber Other companies: Aptevo Therapeutics Inc. (Lead Independent Director · Since at least Aug 1, 2016) | Director · Aug 23, 2010 – May 18, 2016 · Past |
| Robert Kramer Other companies: Aptevo Therapeutics Inc. (President, Director · Jul 15, 2016 – Jul 15, 2016 · Past) | President and CEO, Director · May 31, 2013 – Jun 9, 2023 · Past |
| Seamus Mulligan Other companies: Jazz Pharmaceuticals plc (Director, Jazz Pharmaceuticals plc · Since at least Jan 18, 2012) | Director · Mar 19, 2019 – Mar 19, 2019 · Past |
| Zsolt Harsanyi Other companies: Aptevo Therapeutics Inc. (Director · Since at least Jul 15, 2016) | Independent Director, Chairman of the Board · Since at least Nov 14, 2006 |
| Adam Havey | EVP, Business Operations · Mar 1, 2011 – Jun 9, 2023 · Past |
| Bill Hartzel | Senior Vice President, Manufacturing and Bioservices · Since at least Aug 8, 2023 |
| Coleen Glessner | Executive Vice President Quality and Ethics and Compliance · Since at least Mar 14, 2022 |
| Denise Esposito | CLO · Apr 1, 2007 – Mar 10, 2009 · Past |
| Edward Arcuri | COO · Nov 14, 2006 – May 8, 2007 · Past |
| H Haywood Miller III | Interim CEO · Jun 24, 2023 – Jun 24, 2023 · Past |
| Jerome M Hauer | Director · Nov 14, 2006 – May 25, 2023 · Past |
| Jessica Perl | Senior Vice President, General Counsel and Corporate Secretary · Since at least Oct 29, 2024 |
| John D. Fowler | Independent Director · Since at least Mar 3, 2026 |
| Katherine Strei | EVP, Chief HR Officer · Feb 27, 2018 – Feb 28, 2023 · Past |
| Kathryn C. Zoon | Independent Director · Since at least Nov 8, 2016 |
| Kay Niedzwiecki | Director · Since at least Nov 4, 2026 |
| Mauro Gibellini | SVP, Corporate Dev. · Apr 1, 2007 – Jun 4, 2007 · Past |
| Michelle Pepin | Senior Vice President and Chief Human Resources Officer · Since at least Nov 5, 2026 |
| Paul Williams | Senior Vice President, Products Business · Since at least Jan 9, 2023 |
| Ronald B. Richard | Independent Director · Since at least Oct 17, 2008 |
| Sean Kirk | EVP, Manufacturing & Tech Ops · Feb 25, 2020 – Mar 31, 2021 · Past |
| Simon C Lowry | SVP, R&D, CMO · Since at least Nov 18, 2024 |
| Stephanie Duatschek | Executive Vice President, Chief Growth Officer · Since at least Aug 5, 2026 |
| Steven Chatfield | EVP, BioSciences · Nov 14, 2006 – Mar 14, 2013 · Past |
| Sue Bailey | Director · Jun 14, 2007 – Mar 4, 2021 · Past |
| Sujata Dayal | Independent Director · Since at least Jul 15, 2022 |
| Thomas Zink | SVP & CMO · Nov 14, 2006 – May 17, 2007 · Past |